Jul 2026· Conference on Artificial Intelligence in Medicine in Europe· pp. 38-48· 1 citation· 15 references
Computer Science
TL;DR
It is suggested that LLMs can support clinically meaningful, training-free CKD screening using minimal community-accessible patient features, offering a practical complement to conventional ML methods in real-world screening contexts.
Abstract
Early screening of chronic kidney disease (CKD) is essential for preventing irreversible progression; however, many machine learning (ML)-based screening methods remain difficult to deploy in community and resource-limited screening settings due to their reliance on large labeled datasets, resource-intensive pathology tests, or high-dimensional clinical features, and limited robustness to population and distributional shifts. This study examines the feasibility of using large language models (LLMs) for early-stage CKD screening in a zero-shot setting, without dataset-specific training. We propose a feature-guided zero-shot framework that evaluates LLM performance using a selected set of clinically meaningful, readily available community-based features, rather than exhaustive clinical inputs. Feature selection was guided by ML-based analysis to identify a compact, clinically relevant subset of variables. Tabular patient records were subsequently serialized into text using standardized prompt templates to enable zero-shot inference. The zero-shot performance of four LLMs (LLaMA-3, Qwen-3, Mistral, and GPT-4o-mini) was evaluated using both the full feature set and the selected subset. Generalizability was assessed across three heterogeneous CKD datasets spanning three countries. Across models and datasets, the selected feature set yielded consistent and statistically significant improvements in balanced accuracy and probability estimates, achieving performance levels suitable for screening purposes. These findings suggest that LLMs can support clinically meaningful, training-free CKD screening using minimal community-accessible patient features, offering a practical complement to conventional ML methods in real-world screening contexts.
This study evaluates the effectiveness of large language models for CKD screening under zero-shot and few-shot in-context learning settings and compares them with traditional ML and DL methods and proposes a framework that uses clinically selected tabular features and structured prompt templates to enable LLM-based inf...
The proposed GPT2-based table-to-text framework provides a practical and clinically interpretable approach for disease prediction from limited structured healthcare data and demonstrates strong potential for early risk detection, transparent clinical decision support, and reliable deployment in real-world low-resource...
S. Bin Akter, S. Akter, D. Eisenberg et al.· medRxiv· 0 citations
This study addresses the limitations of traditional diagnostic methods and the "black-box" nature of standard deep learning by developing an explainable, attention-driven hybrid Convolutional Neural Network- Support Vector Machine (CNN-SVM) framework that provides a robust, transparent, and low-cost diagnostic utility.
Ederi Felicia Azibanigha· International Journal of Com...· 0 citations
Liver cancer primarily develops in patients with chronic liver disease (CLD), yet most cases are diagnosed at advanced stages with poor prognosis. While CLD surveillance generates extensive longitudinal data, its free-text nature hinders large-scale research. To address this, we developed a scalable framework using o...
H. Paverd, Ze-Yu Gao, G. Mahani et al.· npj Precision Oncology· 0 citations
It is demonstrated that LLMs can be effectively employed to generate supervision labels for medical imaging tasks and that the proposed approach offers a scalable and low-cost solution for preliminary disease screening, particularly in healthcare environments with limited expert availability.
Qing-Yuan Zhang, Pardeep Vasudev, Kezhi Li et al.· Frontiers in Digital Health· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.